CDK5RAP3 and gastric cancer: As CSCs are generally resistant to chemotherapy, we examined the effects of altered CDK5RAP3 expression on gastric CSCs’ sensitivity to 5-fluorouracil and cisplatin, two commonly used chemotherapeutics for gastric cancer.